Last checked at 23 Apr 2021 15:42
European regulator says AstraZeneca vaccine benefits increase with age
European regulator says AstraZeneca vaccine benefits increase with age
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
11,352.00
Bid:
11,348.00
Ask:
11,350.00
Change:
0.00 (0.00%)
Spread:
2.00 (0.018%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
11,352.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.23 Apr 2021 15:34
UPDATE 2-EU backs AstraZeneca COVID-19 vaccine as blood clot reviews continue
(Adds details)April 23 (Reuters) - Europe's drug regulator reiterated on Friday the benefits of AstraZeneca's COVID-19 vaccine outweigh any risks, delivering an assessment based on continuing reviews into rare blood clots to help countries determi...
Read more23 Apr 2021 14:10
UPDATE 1-Norway offers mRNA COVID-19 vaccines to those who first got AstraZeneca's
(Adds quote, detail)OSLO, April 23 (Reuters) - Norway will offer those who have received a dose of the AstraZeneca vaccine against COVID-19 to take an injection from an mRNA vaccine as their second dose, the health ministry said on Friday.Norway o...
Read more23 Apr 2021 14:04
UPDATE 1-Brazil's COVID-19 vaccination program at risk due to 2nd dose no-shows
(Adds Health Ministry comment)By Pedro FonsecaRIO DE JANEIRO, April 23 (Reuters) - Brazil’s COVID-19 vaccination program is being put at risk by people failing to show up for their second shot, with 1.5 million people missing appointments for the ...
Read more23 Apr 2021 13:32
Norway offers mRNA COVID-19 vaccines to those who first got AstraZeneca's
OSLO, April 23 (Reuters) - Norway will offer those who have received a dose of the AstraZeneca vaccine against COVID-19 injections from mRNA vaccines as their second dose, the health ministry said on Friday.Norway on March 11 suspended the rollout...
Read more23 Apr 2021 13:19
No decision yet on EU legal action against AstraZeneca - EU exec head
PUURS, Belgium, April 23 (Reuters) - The European Union has not yet taken a decision whether to launch legal action against AstraZeneca over the company's failure to deliver the contracted doses to the 27-nation bloc, European Commission head Urs...
Read more23 Apr 2021 13:12
UPDATE 1-Swedish health agency extends pause on J&J vaccine
(Adds details, quote)STOCKHOLM, April 23 (Reuters) - Sweden's Public Health Agency said on Monday it was extending its recommendation against beginning vaccinations using the COVID-19 vaccine made by Johnson & Johnson.The agency said the vaccine c...
Read more23 Apr 2021 13:00
Brazil's COVID-19 vaccination program at risk due to 2nd dose no-shows
By Pedro FonsecaRIO DE JANEIRO, April 23 (Reuters) - Brazil’s COVID-19 vaccination program is being put at risk by people failing to show up for their second shot, with 1.5 million people missing appointments for the follow-up dose needed to maxim...
Read more23 Apr 2021 12:53
Germany says AstraZeneca lawsuit "not priority" for now
Germany says AstraZeneca lawsuit "not priority" for now
Read more23 Apr 2021 12:42
Swedish Health Agency recommends continued pause on Johnson & Johnson vaccine
STOCKHOLM, April 23 (Reuters) - Sweden's Public Health Agency said on Monday it was extending its recommendation against starting vaccinations using a vaccine made by Johnson & Johnson.The agency said on April 14 it would not start using the COVI...
Read more23 Apr 2021 09:46
EU legal action against AstraZeneca won't help get more vaccines -German health minister
BERLIN, April 23 (Reuters) - Launching legal action against AstraZeneca will not help the European Union secure vaccine doses more quickly, German Health Minister Jens Spahn said on Friday."It is much more important to me that I get these vaccines...
Read more23 Apr 2021 09:22
J&J COVID-19 vaccine is safe and effective - German health official
BERLIN, April 23 (Reuters) - Johnson & Johnson's COVID-19 vaccine is safe and effective and its side effects are very rare, the head of Germany's vaccine regulator said on Friday.Klaus Cichutek, the head of the Paul-Ehrlich-Institut, said Germany...
Read more23 Apr 2021 09:05
UPDATE 2-London stocks end the week lower despite strong economic data
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK PMIs hit highest since Nov. 2013* FirstGroup jumps on $4.6 billion sale of two U.S. units* Mid-cap stocks snap four week winning streak*...
Read more23 Apr 2021 05:59
WHO jab experts want more AstraZeneca clot data from outside Europe
WHO jab experts want more AstraZeneca clot data from outside Europe
Read more22 Apr 2021 18:15
British regulator says AstraZeneca COVID shot clots rise to 168
LONDON, April 22 (Reuters) - Britain's medicines regulator on Thursday said there had been 168 major blood clots following a dose of AstraZeneca's COVID-19 vaccine, a rate of 7.9 clots per million doses, a jump in incidence from the previous week...
Read more